Showing results (111-120 of 125) with videos related to

Sort By:
Pageof 13
British Journal of Haematology|April 13, 2024
Mixed histiocytic neoplasms: A multicentre series revealing diverse somatic mutations and responses to targeted therapyJoshua S Friedman, Benjamin H Durham, Anne S Reiner, et al.
Cancer|April 30, 2024
Langerhans cell histiocytosis: NACHO update on progress, chaos, and opportunity on the path to rational curesKevin Bielamowicz, Peter Dimitrion, Oussama Abla, et al.
Neuro-Oncology|May 23, 2022
Multi-institutional study of the frequency, genomic landscape, and outcome of IDH-mutant glioma in pediatricsKee Kiat Yeo, Sanda Alexandrescu, Jennifer A Cotter, et al.
Biorxiv : the Preprint Server for Biology|August 12, 2024
Mechanism of neurodegeneration mediated by clonal inflammatory microgliaRocio Vicario, Stamatina Fragkogianni, Maria Pokrovskii, et al.
Cancer Discovery|May 1, 2024
A Next-Generation BRAF Inhibitor Overcomes Resistance to BRAF Inhibition in Patients with BRAF-Mutant Cancers Using Pharmacokinetics-Informed Dose EscalationRona Yaeger, Meredith A McKean, Rizwan Haq, et al.
Neuron|March 13, 2025
Role of clonal inflammatory microglia in histiocytosis-associated neurodegenerationRocio Vicario, Stamatina Fragkogianni, Maria Pokrovskii, et al.
Blood Advances|May 2, 2025
NTRK1-rearranged histiocytosis: clinicopathologic and molecular featuresRivers Fragneau, Sylvie Fraitag, Paul G Kemps, et al.
Nature Medicine|November 27, 2019
Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasmsBenjamin H Durham, Estibaliz Lopez Rodrigo, Jennifer Picarsic, et al.
Acta Neuropathologica|September 12, 2025
Prospective characterization of germline variants in patients with gliomas and glioneuronal tumorsSubhiksha Nandakumar, Miika Mehine, Yelena Kemel, et al.
Cancer Cell|October 24, 2025
RAF-independent MEK mutations drive refractory histiocytic neoplasms but respond to ERK inhibitionEli L Diamond, Jean-Francois Emile, Takeshi Fujino, et al.
Pageof 13